ICON PLC (ICLR)
About ICON PLC
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $8.3B
- Net income
- $229.3M
- Total assets
- $16.3B
- Market cap
- $11.4B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $11.4B
- Shares outstanding
- 69.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 15, 1998
Icon PLC (ICLR) Stock Price
- Profitable — net income of $229.3M in FY2025.
- Trading 18% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review ICON PLC.
Write a review
News about ICON PLC
News & sentiment via Polygon.io
Icon PLC: frequently asked questions
Is Icon PLC an American company?
Icon PLC is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Icon PLC publicly traded?
Yes — Icon PLC is a publicly traded company. Its stock trades under the ticker symbol ICLR on the NASDAQ.
What does Icon PLC do?
Icon PLC is an American Pharmaceuticals company in the Health & Beauty sector.
When was Icon PLC founded?
Icon PLC was founded in 1990.
